Millennium Management
CLCD

Millennium Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Millennium Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-26,135
Closed -$997K – 3997
2016
Q3 		$997K Buy
+26,135
New +$386K ﹤0.01% 2268
2016
Q2 		– Sell
-10,042
Closed -$62K – 3869
2016
Q1 		$62K Buy
10,042
+19
+0.2% +$119 ﹤0.01% 3137
2015
Q4 		$84K Sell
10,023
-9,811
-49% -$51.6K ﹤0.01% 3263
2015
Q3 		$77K Sell
19,834
-28,536
-59% -$211K ﹤0.01% 3303
2015
Q2 		$430K Buy
+48,370
New +$415K ﹤0.01% 2708

Other funds holding CLCD

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Millennium Management's CLCD Position: Q4 2016 in Review

Millennium Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q4 2016, closing a stake of 26,135 shares — an estimated $997K sold.

Millennium Management first reported a position in CLCD in Q2 2015 and held it in 5 quarters. The position peaked at $997K in Q3 2016. 76 funds tracked by Wall St. Rank hold CLCD as of Q4 2016.

  • Millennium Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Millennium Management sold 26,135 CoLucid Pharmaceuticals, Inc. shares in Q4 2016, an estimated $997K.
  • Millennium Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
  • Millennium Management's CoLucid Pharmaceuticals, Inc. position peaked at $997K in Q3 2016.
  • 76 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.